CMO Purchases 932.4K Shares of This Major Medical Company
Galera Therapeutics Insider Purchase: A Strategic Move or a Signal of Confidence?
Galera Therapeutics Inc. (NASDAQ: GRTX), a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for transformational improvements in cancer treatment, has recently seen a significant insider purchase. Yair Schneid, 10% owner of Galera, bought 932.4k shares at $0.18 each. This move is intriguing and deserves a closer look. $Galera Therapeutics (GRTX.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment